Skip to content
Clinical Trials – home
IrelandBack to Ireland

Clinical trials in Dooradoyle

40 clinical trials in Dooradoyle, Ireland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Dooradoyle at a glance
40
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

40 trials in Dooradoyle

Open in trial search

Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:Unicancer

Study of Trastuzumab Deruxtecan for Patients with Early Stage HER2-Positive Breast Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Paclitaxel
  • Sponsor:Cancer Trials Ireland

Study on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Unicancer

Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Emn Trial Office S.r.l. Impresa Sociale

Study comparing RMC-6236 and docetaxel in previously treated patients with advanced or metastatic non-small cell lung cancer who have RAS mutations

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Daraxonrasib
  • Sponsor:Revolution Medicines Inc.

Study of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:BeOne Medicines AG

Study Comparing Zilovertamab Vedotin with Drug Combination for Untreated Patients with Diffuse Large B-Cell Lymphoma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Effects of Darolutamide and Drug Combination for Patients with Metastatic Hormone-Naïve Prostate Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Anaemia+1

Recruiting

Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Elritercept
  • Sponsor:Takeda Development Center Americas Inc.

Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:University Of Cologne

Cystic fibrosis

Recruiting

Study of VX-121, Tezacaftor, and Deutivacaftor for Children Aged 1-11 with Cystic Fibrosis

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Deutivacaftor
  • Sponsor:Vertex Pharmaceuticals Inc.

Study on Tranexamic Acid and Sodium Chloride for Patients with Stroke-Related Brain Bleeding

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:University Of Nottingham

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Dooradoyle

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on chronic lymphocytic leukemia (CLL) treatment approaches, comparing the effectiveness of different therapeutic combinations including ibrutinib monotherapy versus combination treatments with venetoclax and obinutuzumab.

  • Treatment-naive CLL patients
  • Progression-free survival assessment
  • Novel therapy combinations

This research aims to establish optimal treatment protocols for previously untreated CLL patients.

02 Prostate Cancer Research

Groundbreaking studies in metastatic prostate cancer treatment, evaluating the effectiveness of ADT combined with darolutamide in patients with specific clinical characteristics.

  • Castration-naïve metastatic disease
  • Radiographic progression monitoring
  • Targeted therapy approaches

Focused on improving outcomes for vulnerable patients with newly diagnosed metastatic disease.

03 Advanced Prostate Cancer Therapeutics

Investigation of combination therapies for metastatic castration-resistant prostate cancer (mCRPC), examining the potential benefits of combining pembrolizumab with enzalutamide.

  • Overall survival assessment
  • Radiographic progression tracking
  • Immunotherapy combinations

Evaluating innovative treatment strategies to improve outcomes in resistant disease states.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.